[CHRS] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
06-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 28.65%
YoY- -44.88%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 74,568 58,716 32,436 45,352 45,424 60,151 60,115 15.43%
PBT -40,021 -42,869 -75,729 -58,870 -86,650 -50,150 -96,084 -44.19%
Tax -380 11,560 -949 7,377 6,201 6,137 15,159 -
NP -39,641 -42,869 -74,780 -66,247 -92,851 -56,287 -111,243 -49.70%
Tax Rate - - - - - - - -
Total Cost 114,209 101,585 107,216 111,599 138,275 116,438 171,358 -23.68%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -53.16 -73.01 -230.55 -146.07 -204.41 -93.58 -185.05 -56.42%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.41 -0.49 -0.94 -0.85 -1.19 -0.73 -1.44 -56.68%
EPS Diluted -0.41 -0.49 -0.94 -0.85 -1.19 -0.73 -1.44 -56.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.